A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia
about
Biological Properties of Tocotrienols: Evidence in Human Studiesδ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasisPharmacokinetics and safety of vitamin E δ-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolitesEvaluation of Pharmacokinetics, and Bioavailability of Higher Doses of Tocotrienols in Healthy Fed HumansOxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment.Targeting reactive oxygen species in development and progression of pancreatic cancer.Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities.Berries and other natural products in the pancreatic cancer chemoprevention in human clinical trials.Natural Forms of Vitamin E as Effective Agents for Cancer Prevention and Therapy.Inducers of Senescence, Toxic Compounds, and Senolytics: The Multiple Faces of Nrf2-Activating Phytochemicals in Cancer Adjuvant Therapy.Antioxidant Tocols as Radiation Countermeasures (Challenges to be Addressed to Use Tocols as Radiation Countermeasures in Humans).A 12-week evaluation of annatto tocotrienol supplementation for postmenopausal women: safety, quality of life, body composition, physical activity, and nutrient intake.
P2860
Q28067638-DB000D86-D028-4FB3-A149-4C739D00A499Q33761817-D793E9F4-F678-48A4-98A3-10839BA4477AQ37082597-1F622A89-B6AE-47DF-8BFA-93F09CCD1BDAQ37143024-B9B82885-8FC4-423E-86E5-14731DD1850CQ37729938-3BEFFB7F-E44D-4450-A10D-4FC40D46737FQ39007517-766A8293-BED2-44C3-97B8-5C4C1229EFE1Q48129928-061391A7-1111-4A76-9E5D-AF1B250D22B1Q49415169-8C36975B-5038-484E-96CC-F2D6947A1E8DQ49988596-25672019-95FB-4B62-8508-B62E52B4BCFDQ52331716-F06496DD-2484-475B-ABD0-BD240CF957E3Q55177665-951EA439-25BD-4A94-B8F8-0FDE6C1BE907Q55514074-79D56890-AB49-4851-BA6D-208935A5222B
P2860
A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A Phase I Safety, Pharmacokine ...... th Pancreatic Ductal Neoplasia
@ast
A Phase I Safety, Pharmacokine ...... th Pancreatic Ductal Neoplasia
@en
type
label
A Phase I Safety, Pharmacokine ...... th Pancreatic Ductal Neoplasia
@ast
A Phase I Safety, Pharmacokine ...... th Pancreatic Ductal Neoplasia
@en
prefLabel
A Phase I Safety, Pharmacokine ...... th Pancreatic Ductal Neoplasia
@ast
A Phase I Safety, Pharmacokine ...... th Pancreatic Ductal Neoplasia
@en
P2093
P2860
P1433
P1476
A Phase I Safety, Pharmacokine ...... th Pancreatic Ductal Neoplasia
@en
P2093
Anthony Neuger
Barbara Centeno
Dung-Tsa Chen
Gregory M Springett
Kazim Husain
Mokenge P Malafa
Richard M Lush
Saïd Sebti
Tai Z Hutchinson
P2860
P304
P356
10.1016/J.EBIOM.2015.11.025
P577
2015-11-14T00:00:00Z